Here are four quick points:
1. Medtronic lost 0.71 percent in the last trading session.
2. Eight analysts rated the stock as “buy,” 12 rated it as “outperform” and five rated is as “hold.”
3. Analysts gave a consensus estimate of $1.27 per share.
4. Wall Street analysts predict Medtronic will have earnings of $4.37 per share for the full year.
5. Analysts anticipate Medtronic will keep an annual growth of 6.43 percent over the next five years.
More articles on devices:
DJO Global 2015 net sales hit $308M; Net loss hits $349.9M: 8 things to know
Mesoblast’s Mesenchymal Precursor Cells receives key patent — 5 takeaways
SpineGuard announces full-year 2015 financial results: 9 facts
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
